A phase 2, open-label study of brentuximab vedotin in...

  • Main
  • 2019 / 4
  • A phase 2, open-label study of brentuximab vedotin in...
Investigational New Drugs 2019 / 4

A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors

Sharman, Jeffrey P., Wheler, Jennifer J., Einhorn, Lawrence, Dowlati, Afshin, Shapiro, Geoffrey I., Hilton, John, Burke, John M., Siddiqi, Tanya, Whiting, Nancy, Jalal, Shadia I.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-019-00768-6
Date:
April, 2019
File:
PDF, 568 KB
2019
Conversion to is in progress
Conversion to is failed